7 Questions for Correlia Biosystems Co-Founder Akwasi Apori

A ​CITRIS Foundry​ company, Correlia Biosystems represents ​the next generation of the life science industry. With their patented nanomaterial, they ​develop microscale tools to accelerate molecular interactions to measure proteins, thereby ​reducing the cost and time of drug development, clinical trials, and patient testing and monitoring​. Founded in 2013, the eight-employee company is headquartered in Berkeley and has raised $2.6 million in funding. They are already running a pilot service business and they plan to launch their first commercial instrument in 2021. Akwasi Apori received his PhD in bioengineering at UC Berkeley after earning a bachelor’s and master’s degree in aeronautics and astronautics at MIT. In 2013, Correlia Biosystems joined the CITRIS Foundry, the in-house incubator of the multicampus CITRIS and the Banatao Institute headquartered at UC Berkeley.